Becton Dickinson & Co (BDX) community

BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3017% above fair value

$215.71+1.19 (+0.55%)

Close on Nov 12, 2026Market cap $58.76BP/E 65.2Yield 1.93%

Community

Notes and questions about Becton Dickinson from other investors

No posts about BDX yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Becton Dickinson's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Aug 21, 1998
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BDX.

Compare: BDX vs BSX · BDX vs BAX · BDX vs MDLN · BDX vs SYK · BDX vs MMM

Revenue growth17.4% · median 6.6%

Gross margin46.9% · median 39.5%

Operating margin10.7% · median 18.7%

Net margin4.0% · median 13.8%

Company	Revenue	Growth
MDLN	$30.68B	–
SYK	$26.30B	+7.9%
MMM	$25.25B	+1.7%
BDX	$23.25B	+17.4%
BSX	$21.07B	+8.9%
BAX	$11.61B	+5.3%

Company

Next earnings (est.): Feb 8, 2027, before open
Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: September 30
Employees: 72,000
Held by institutions: 100.0%
Auditor: ERNST& YOUNG LLP
SEC CIK: 10795

Advertisement
300 × 250

See a number that looks wrong?